Biocon Faces Further Downside After Key Technical Breakdown

On 8th August 2025,

stock price fell sharply by 5.72%, closing below its 200-day moving average—a critical long-term support level that now turns into a major resistance. This technical breakdown signals further potential downside, as the 200-day moving average often acts as a strong barrier for price recovery. Notably, a bearish crossover between the 5-day and 20-day moving averages was observed on 5th August 2025, which has since triggered an approximate 8% decline in the stock. This reinforces the current downward momentum. The overall view remains bearish until the stock manages to reclaim and close above the 200-day moving average. In the interim, traders may anticipate selling pressure to persist, with any bounce likely facing resistance near this key level.